Report Description of the UAE Dermatology Treatment Drugs Market Analysis

Research Scope and Assumption

• The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)


• The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis


• We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses


• All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis


• Inflation has not been accounted for in order to estimate and forecast the market


• Numbers may not add up due to rounding off

Reason to buy the report:

• Facilitate decision-making based on strong current and forecast data for UAE Dermatology Treatment Drugs Market Analysis


• Develop strategies based on the latest regulatory framework


• Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market


• Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the UAE Dermatology Treatment Drugs Market Analysis


• Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders


• To strategically profile key players and comprehensively analyze their market shares and core competencies


• We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

UAE Dermatology Treatment Drugs Market Analysis Executive Summary

Dermatology is a medical field that deals with the diagnosis, prevention, and treatment of various skin, nail, and hair-related diseases such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also referred to as dermatologic, are products that are applied topically to the skin.

Market Size and Key Findings

The UAE Dermatology Treatment Drugs Market Analysis size stood at around USD xx% billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 7% during the forecast period.

Middle East Dermatology Drugs Market is expected to grow by 2028, at a CAGR of 7% between 2021 and 2028.



Market Dynamics

Market Growth Drivers Analysis

The rising number of patients suffering from skin infections or disorders, such as scars, acne, dermatitis, etc., is likely to spur the growth opportunities for the market in the forecast period. The increasing awareness regarding numerous dermatology products curing skin problems and the surging product portfolios contributes to the market growth.

Market Restraints

High dependency on imports and frequent drug recalls by the Ministry of Health Saudi Arabia is the biggest challenge that could restrain the market growth.

Covid-19 Market Impact Analysis

Due to the outbreak of the COVID-19 pandemic, the Middle East dermatology drug market came to a standstill position due to the temporary closure of dermatology-clinics during the lockdown. However, the market can regain its pace in the forecast period due to lockdown relaxations by the government.

Competitive Landscape

Key Players

The major players covered in the report are Novartis AG, Pfizer Inc., Eli Lilly and Company., Johnson & Johnson Services, Inc., Almirall, S.A, Mylan N.V., Sun Pharmaceutical Industries Ltd., UCB S.A., Belgium, Glenmark Pharmaceuticals Limited, Tolmar Pharmaceuticals, Inc., GlaxoSmithKline plc., Galderma Laboratories, L.P., Teva Pharmaceutical Industries Ltd., LEO Pharma A/S, MELINTA THERAPEUTICS, INC. - THE ANTIBIOTICS COMPANY, Mayne Pharma Group Limited, BIOFRONTERA AG, AbbVie Inc. among others.

Products in Pipeline

• Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions. Their pipeline refers to drugs in development, including those in preclinical testing, clinical development, regulatory approval and lifecycle management.

Notable Recent Deals

• 75-year-old British expat undergoes successful cornea transplant surgery in the UAE


• KBBO Group becomes the majority shareholder of a one of a kind Population Health Management Delivery System company, Mobile Doctors 24-7


• In November 2018, KBBO Group and Guggenheim Partners Announce JV

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The Emirates Dermatology Society is proud to announce the 4th yearly EDS Conference. This premier conference is scheduled has been held on 25 27 November 2021, InterContinental Dubai Festival City, in Dubai United Arab Emirates. The aim of Emirates Dermatology Society Conference 2021 is to provide a forum of the highest standard for scientific (clinical & experimental), educational and social exchange between professionals involved in Dermatology care (adult & paediatrics) in order to achieve progress in the clinical care of patients. It also aims to build bridges between dermatologists practicing all over the world to easily exchange knowledge and experience.

The Emirates Dermatology Society is a non-profit medical society founded in 2002 under the supervision of the Emirates Medical Association comprising of Dermatologists, Aestheticians, and Skin Specialists who are committed in keeping up with the dynamic trends in the field of Dermatology.

The Emirates Dermatology Society regularly holds workshops, conferences, and exhibitions in partnership with various organizations such as the International Peelings Society, Oman Dermatology Society, International Master Course on Aging Science, Swiss Academy of Cosmetic Dermatology and Aesthetic Medicine, and Saudi Society of Dermatology. The main goal of the society is to discover new and effective methods in the improvement of medical conditions of patients.

• The Emirates Dermatology Society plays a key role in the continuous improvement in the quality of dermatology services in the UAE and the wider region.


• The Emirates Dermatology Society has an active management committee that oversees the day to day running of the organization.


• It brings together the dermatologist in the UAE so they can share their experiences and knowledge with their colleagues